Industry luminaries Betsy Holden and Karen Katen to help guide the firm
to its next level of growth
LISLE, Ill, Dec. 11, 2012 /CNW/ - Catamaran Corp. (NASDAQ: CTRX, TSX:
CCT), a leading provider of pharmacy benefit management (PBM) and
technology services, today announced that it appointed Betsy Holden and
Karen Katen to Catamaran's Board of Directors, effective December 10,
2012. Ms. Holden and Ms. Katen will round out the firm's board which
includes a diverse array of seasoned business leaders representing
leading healthcare, IT, private equity, and consumer product companies.
"The appointment of Betsy Holden and Karen Katen - two of the most
esteemed women in business today - to Catamaran's board will further
enhance our successful shepherding of shareholder interests and our
ability to deliver value to clients," said Mark Thierer, Chairman and
CEO of Catamaran. "Together, Betsy, with a proven track record of value
creation as former CEO of one of the world's most recognized brands,
and Karen, a well-respected executive with an impressive healthcare
pedigree, bolster Catamaran's commitment to driving smart growth."
Ms. Holden, a Senior Advisor to McKinsey & Company, works with clients
across industries on strategy, marketing, innovation and board
effectiveness initiatives. Prior to her current position, she was
co-CEO of Kraft Foods and CEO of Kraft Foods North America, where she
built a strong record of success in brand building, organic growth and
cost management for North America's largest food company at the time.
Ms. Katen is a Senior Advisor to Essex Woodlands, a healthcare
investment firm, where she focuses on building best-of-breed
companies. Prior to this, Ms. Katen served as Vice Chairman of Pfizer,
responsible for providing a broad array of innovative human-health
services. With more than 30 years of experience in the healthcare
industry, including guiding Pfizer's industry-leading portfolio, Ms.
Katen was recognized among Fortune magazine's "50 Most Powerful Women in Business" for eight consecutive
Catamaran, the industry's fastest-growing pharmacy benefit manager,
helps organizations and the communities they serve take control of
prescription drug costs. Managing more than 250 million prescriptions
each year on behalf of 25 million members, our flexible, holistic
solutions improve patient care and empower individuals to take charge
of their health. Processing one in every five prescription claims in
the U.S., Catamaran's skill and scale deliver compelling financial
results and sustainable improvement in the overall health of members.
Catamaran is headquartered in Lisle, Ill. with multiple locations in
the U.S. and Canada. For more information, please visit www.catamaranRx.com.
For further information:
Tel: (630) 577-4871